Population
Patients receiving cancer therapies, including chemotherapy and radiation therapy
Design
Review
Authors
Loading...
Prompts clinician awareness of cardiotoxicity risks in cancer therapy; leaves open validation of surveillance strategies in prospective studies.
Awareness and early recognition of cancer therapy-related cardiotoxicity, along with appropriate surveillance and prevention strategies, can improve cardiac survival and patient outcomes.
Hamo et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: